Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer

por Loo, Claudette E., Rigter, Lisanne S., Pengel, Kenneth E., Wesseling, Jelle, Rodenhuis, Sjoerd, Peeters, Marie-Jeanne T. F. D. Vrancken, Sikorska, Karolina, Gilhuijs, Kenneth G. A.
Publicado 2016

Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

por van Ramshorst, Mette S., Teixeira, Suzana C., Koolen, Bas B., Pengel, Kenneth E., Gilhuijs, Kenneth G., Wesseling, Jelle, Rodenhuis, Sjoerd, Valdés Olmos, Renato A., Rutgers, Emiel J., Vogel, Wouter V., Sonke, Gabe S., Vrancken Peeters, Marie-Jeanne T.
Publicado 2017

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes

por Schmitz, Alexander M. Th., Teixeira, Suzana C., Pengel, Kenneth E., Loo, Claudette E., Vogel, Wouter V., Wesseling, Jelle, Rutgers, Emiel J. Th., Valdés Olmos, Renato A., Sonke, Gabe S., Rodenhuis, Sjoerd, Vrancken Peeters, Marie Jeanne T. F. D., Gilhuijs, Kenneth G. A.
Publicado 2017